Search research articles
Contact Us
Filters
Showing results (131-140 of 148) with videos related to
Page
of 15
Sort By:
Ebiomedicine
|
February 12, 2026
Disulfiram metabolite Cu(DDC)<sub>2</sub> enhances radionuclide uptake in vivo revealing insights into tumoural ablation resistance
Katie Brookes, Jessica S Fear, Caitlin E M Thornton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 8, 2019
The Immune Microenvironment in Hormone Receptor-Positive Breast Cancer Before and After Preoperative Chemotherapy
Adrienne G Waks, Daniel G Stover, Jennifer L Guerriero, et al.
Cancer Research
|
April 25, 2020
Stromal Platelet-Derived Growth Factor Receptor-β Signaling Promotes Breast Cancer Metastasis in the Brain
Katie A Thies, Anisha M Hammer, Blake E Hildreth, et al.
BMC Cancer
|
May 19, 2021
Genomic features of rapid versus late relapse in triple negative breast cancer
Yiqing Zhang, Sarah Asad, Zachary Weber, et al.
NPJ Precision Oncology
|
September 18, 2021
Circulating tumor DNA is readily detectable among Ghanaian breast cancer patients supporting non-invasive cancer genomic studies in Africa
Samuel Terkper Ahuno, Anna-Lisa Doebley, Thomas U Ahearn, et al.
Frontiers in Digital Health
|
October 24, 2022
Exploring approaches for predictive cancer patient digital twins: Opportunities for collaboration and innovation
Eric A Stahlberg, Mohamed Abdel-Rahman, Boris Aguilar, et al.
Cell Reports. Medicine
|
November 20, 2024
Molecular adaptation to neoadjuvant immunotherapy in triple-negative breast cancer
Carsten Denkert, Andreas Schneeweiss, Julia Rey, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 5, 2025
Integration of Gene Expression and Digital Histology to Predict Treatment-Specific Responses in Breast Cancer
Frederick M Howard, James Dolezal, Hanna Hieromnimon, et al.
Biomolecules
|
November 11, 2022
Replicative Instability Drives Cancer Progression
Benjamin B Morris, Jason P Smith, Qi Zhang, et al.
The New England Journal of Medicine
|
January 28, 2026
Palbociclib for Hormone-Receptor-Positive, HER2-Positive Advanced Breast Cancer
Otto Metzger, Sumithra Mandrekar, Shom Goel, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 148) with videos related to
Sort By:
Page
of 15
Ebiomedicine
|
February 12, 2026
Disulfiram metabolite Cu(DDC)<sub>2</sub> enhances radionuclide uptake in vivo revealing insights into tumoural ablation resistance
Katie Brookes, Jessica S Fear, Caitlin E M Thornton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 8, 2019
The Immune Microenvironment in Hormone Receptor-Positive Breast Cancer Before and After Preoperative Chemotherapy
Adrienne G Waks, Daniel G Stover, Jennifer L Guerriero, et al.
Cancer Research
|
April 25, 2020
Stromal Platelet-Derived Growth Factor Receptor-β Signaling Promotes Breast Cancer Metastasis in the Brain
Katie A Thies, Anisha M Hammer, Blake E Hildreth, et al.
BMC Cancer
|
May 19, 2021
Genomic features of rapid versus late relapse in triple negative breast cancer
Yiqing Zhang, Sarah Asad, Zachary Weber, et al.
NPJ Precision Oncology
|
September 18, 2021
Circulating tumor DNA is readily detectable among Ghanaian breast cancer patients supporting non-invasive cancer genomic studies in Africa
Samuel Terkper Ahuno, Anna-Lisa Doebley, Thomas U Ahearn, et al.
Frontiers in Digital Health
|
October 24, 2022
Exploring approaches for predictive cancer patient digital twins: Opportunities for collaboration and innovation
Eric A Stahlberg, Mohamed Abdel-Rahman, Boris Aguilar, et al.
Cell Reports. Medicine
|
November 20, 2024
Molecular adaptation to neoadjuvant immunotherapy in triple-negative breast cancer
Carsten Denkert, Andreas Schneeweiss, Julia Rey, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 5, 2025
Integration of Gene Expression and Digital Histology to Predict Treatment-Specific Responses in Breast Cancer
Frederick M Howard, James Dolezal, Hanna Hieromnimon, et al.
Biomolecules
|
November 11, 2022
Replicative Instability Drives Cancer Progression
Benjamin B Morris, Jason P Smith, Qi Zhang, et al.
The New England Journal of Medicine
|
January 28, 2026
Palbociclib for Hormone-Receptor-Positive, HER2-Positive Advanced Breast Cancer
Otto Metzger, Sumithra Mandrekar, Shom Goel, et al.
Page
of 15